Background: Laminin a2 chain mutations cause congenital muscular dystrophy with dysmyelination neuropathy (MDC1A). Previously, we demonstrated that laminin a1 chain ameliorates the disease in mice. Dystroglycan and integrins are major laminin receptors. Unlike laminin a2 chain, a1 chain binds the receptors by separate domains; laminin globular (LG) domains 4 and LG1-3, respectively. Thus, the laminin a1 chain is an excellent tool to distinguish between the roles of dystroglycan and integrins in the neuromuscular system.
Introduction
Congenital muscular dystrophy type 1A (MDC1A) is an autosomal recessive disorder caused by mutations in the gene encoding laminin (LM) a2 chain. The general clinical hallmarks of MDC1A include neonatal onset of muscle weakness, hypotonia often associated with joint contractures, inability to stand and walk, elevated levels of creatine kinase, white matter abnormalities and dysmyelination neuropathy. Histological changes of muscles comprise fiber size variability, massive degeneration and extensive connective tissue infiltration. Most patients die as teenagers since there is no treatment for this devastating disease [1] . Several mouse models for MDC1A exist (e.g. generated LMa2 chain mutants dy 3K /dy 3K and dy W /dy W and the spontaneous mutant mouse strain dy/dy) and they adequately mirror the human condition [2] [3] [4] .
LMs are extracellular proteins formed by a, b and c chains. Together with other extracellular matrix components LMs form specialized extracellular matrices called basement membranes [5] . LM-211 (composed of a2, b1 and c1 chains) is the major LM isoform expressed in muscle and peripheral nerve. Through interaction with transmembrane receptors it regulates major functions of the neuromuscular system and provides structural support to muscle fibers [6] . In muscle, at least two distinct protein complexes are known to be the key receptors for LMa2 chain; dystroglycan and integrin a7b1. Their importance is underscored by the fact that absence of integrin a7 chain, as well as hypoglycosylation of a-dystroglycan cause various forms of congenital muscular dystrophy [7, 8] . Furthermore, different studies involving manipulation of the dystroglycan gene in mice revealed an important role for dystroglycan in skeletal muscle [9] [10] [11] . Several studies indicated that the function of integrin a7 subunit and dystroglycan, being a part of the dystrophinglycoprotein complex, could overlap [12] [13] [14] . However, recent studies show that whereas both dystroglycan and integrin a7 chain contribute to force-production of muscles, only dystroglycan contributes to the preservation of sarcolemmal integrity [15] .
LMa2 chain receptors present in peripheral nerve include dystroglycan, integrins a6b1, a7b1 and possibly integrin a6b4 [16, 17] . Dystroglycan, b1 and b4 integrin subunits have been shown to be important for different aspects of myelination and morphology of peripheral nerves, as revealed by conditional disruption of their genes in Schwann cells [18] [19] [20] . Thus, LM-211 is a central player linking these receptors and their functions in the neuromuscular system. LMa1 chain also binds to dystroglycan, integrin a6b1 and integrin a7b1 (and perhaps integrin a6b4) [17, [21] [22] [23] [24] . Yet, it is not expressed in the neuromuscular system [25] . We have previously explored the possibilities of paralogous gene therapy for MDC1A and demonstrated that LMa1 chain is an excellent substitute for LMa2 chain in murine muscle, peripheral nerve and testis [25] [26] [27] [28] . Additionally, LMa2 chain deficiency leads to perturbed expression of integrin a7 subunit, and reduced expression of the core protein of a-dystroglycan (but not adystroglycan glycosylation), at the sarcolemma [29] [30] [31] . Notably, LMa1 chain overexpression restores integrin a7 chain expression, indicating that this receptor could be crucial for improvement of muscle function in dystrophic animals [32] .
The LMa1 and a2 chains bind dystroglycan and integrins by distinct domains. The a1 chain binds dystroglycan via its Cterminal LG4 domain and integrin binding occurs via a1LG1-3 [33, 34] . This is different from LMa2 chain binding where there is considerable overlap in binding to dystroglycan and integrins. Both a2LG4-5 and a2LG1-3 bind dystroglycan, whereas only a2LG1-3 binds integrins [23, 35] . The LMa1 chain can thus be used more efficiently to distinguish between the roles of LM binding to dystroglycan and integrins in the neuromuscular system. Since LMa1 chain functions almost equally well as a2 chain in the neuromuscular system, we used this subunit in order to dissect the roles of the aLG domains and their receptors in MDC1A pathogenesis and rescue. Hence, we produced and characterized animals completely deficient in LMa2 chain, but instead overexpressing a truncated form of LMa1 chain (dy 3K /dE3 mice) that lacks the dystroglycan binding site (LG4-5 domains at the C-terminus, also known as the E3 fragment), but retains the integrin binding site (LG1-3, see Fig. 1A ) [33, 34] .
Materials and Methods

Ethics statement
All mouse experimentation was approved by the local (Lund district) ethics committee (permit number M62-09). All mice were maintained in animal facilities according to animal care guidelines.
Transgenic construct
Approximately 1 kb of the C-terminal part was removed from mouse full-length LMa1 chain cDNA to generate truncated cDNA (dE3LMa1). An in frame deletion between nucleotides 8248-9289 (corresponding to LG4-5 domains) was accomplished by DraIII-SmaI restriction cutting and fusion of an XhoI site with a BglII site. This DNA was cloned into the pCAGGS vector [25] , containing a CMV enhancer and a bactin promoter.
Transgenic animals
Transgenic mice were generated by microinjections of transgene DNA into the pronucleus of fertilized single-cell C57BL/CBA embryos (Lund Transgenic Core Facility, Lund University, Sweden). Mice carrying dE3LMa1 chain DNA were identified by PCR as described previously [25] . Positive founders overexpressing truncated LMa1 chain in the neuromuscular system (lines No. 3 and 4) were further bred with dy 3K /+ mice [2] , followed by sib breeding to generate LMa2 chain deficient animals that express dE3LMa1 chain (dy 3K /dE3 mice). Dy 3K /dy 3K mice overexpressing full length LMa1 chain (dy 3K LMa1 mice) were previously described [25] [26] [27] [28] . Dy/dy mice used for heart studies were obtained from Jackson Laboratory.
Exploratory locomotion and body and muscle weight analyses
Exploratory locomotion was examined in an open field test. A mouse was placed into a new cage and allowed to explore the cage for 5 min. The time that the mouse spent moving around was measured. For all experiments, 10-week-old dy 3K /dE3 animals (n = 16) were compared with 10-week-old control mice (wild-type or dy 3K /+) (n = 8) and 5-week-old dy 3K /dy 3K mice (n = 6). For weight analysis dy 3K /dE3, control mice and dy 3K /dy 3K animals were sex-and age-matched (5-week-old) (n = 14, n = 3, n = 11, respectively, for females; n = 8, n = 4, n = 8, respectively, for males). Quadriceps and tibialis anterior muscles from 2-month-old wild-type (n = 3), dy 3K /dE3 (n = 3) and 4-week-old dy 3K /dy 3K mice (n = 4) were used to estimate the ratio of wet muscle weight to body weight. Muscles from both legs were weighed and average muscle mass was calculated. Unpaired t-test was used for statistical analysis.
Creatine kinase activity
Blood was collected from the tail vein of 2-month-old control mice (wild-type or dy 3K /+) (n = 10), dy 3K /dE3 (n = 10) and 4-weekold dy 3K /dy 3K mice (n = 3) into EDTA-tubes and spun down two times for 5 minutes at 3500 rpm. CK_P_S_cobas method was used by Clinical Chemistry Laboratory at Skåne University Hospital to quantify enzyme activity in plasma. Unpaired t-test was used for statistical analyses.
Histology and immunofluorescence microscopy
Skeletal muscle, heart, peripheral nerve and spinal roots cryosections (7 mm) from control (wild-type or dy 3K /+), dy 3K /dy 3K , dy/dy, dy 3K /dE3 and dy 3K LMa1 mice were either stained with hematoxylin and eosin or subjected to immunofluorescence analysis using following antibodies: rat monoclonal mAb200 against LMa1LG4 domain [25] , rabbit polyclonal 1057+ against LMa1 LN/LEa domain (N-terminus) (kindly provided by Dr. T. Sasaki) [36] , rabbit polyclonal 1100+ against LMa4, (kindly provided by Dr. T. Sasaki), rabbit polyclonal 1113+ against LMa5 (kindly provided by Dr. T. Sasaki), rat monoclonal MTn15 against tenascin-C [25], rabbit polyclonal U31 against integrin a7B subunit (kindly provided by Dr. U. Mayer) [37] , mouse monoclonal IIH6 against a-dystroglycan (Upstate Biotechnology), mouse monoclonal F1.652 against embryonic myosin heavy chain (Developmental Studies Hybridoma Bank, Iowa), rabbit polyclonal anti-collagen, type IV (Chemicon), mouse monoclonal 46 against caspase-3 (BD Transduction Laboratories). Mouse on mouse kit (Vector) was used for staining with embryonic myosin heavy chain according to manufacturer instructions. Tissues were fixed with 4% PFA at room temperature (for laminin, tenascin-C, embryonic myosin heavy chain, collagen-IV and caspase-3 stainings), or with acetone at 220uC (for integrin a7B) or with 8% formaldehyde, followed by methanol at 220uC (for a-dystroglycan). Sections were analyzed using a Zeiss Axioplan fluorescence microscope. Images were captured using an ORCA 1394 ER digital camera with Openlab 3 software. Images were prepared for publication using Adobe Photoshop software.
Immunoblotting
For LM detection proteins were isolated from 100 mg of dy 3K / dE3 and dy 3K LMa1 muscles (3 mice from each group) by brief sonication in 1 mmol/L EDTA in TBS with 1:25 dilution of protease inhibitors (Complete EDTA-free, Roche Diagnostics). For integrin detection proteins were extracted from 100 mg skeletal homogenized muscle powder of 3 wild-type and dy 3K /dE3 mice in 1% Triton X-100, 50 mM Tris-HCl, pH 7,4; 1 mM CaCl 2 , 1 mM MgCl 2 and 1:25 dilution of Protease Cocktail (Complete EDTA-free, Roche Diagnostics). Samples were incubated for 1 hour and spun down at 4uC. The supernatants were collected and the protein concentration was determined using BCA assay (Pierce). Dystroglycan was isolated using agarose bound wheat germ agglutinin (Vector) and N-acetyl-D-glucosamine (Sigma) as described before [32] . Lysates containing LM, integrin and dystroglycan were separated on 5% or 8% polyacrylamide-SDS gels under reducing or non-reducing conditions. EHS LM (Invitrogen) was used as a control for LM blotting. Proteins were transferred to nitrocellulose membranes (Amersham). Membranes were blocked for 1 hour in 5% non-fat dry milk in 1xTBS with 0.02% Tween-20 and incubated overnight at 4uC with a rabbit polyclonal antibody detecting LMa1LG3 domain (kindly provided by Dr. T. Sasaki); rabbit polyclonal antibody against integrin a7B (kindly provided by Dr. U. Mayer); rabbit polyclonal antibody against b-dystroglycan [25] and mouse monoclonal antibody IIH6 against a-dystroglycan. Detection was performed with ECL kit (Amersham). Expression of LMa1 chain, integrin a7B subunit, a-and b-dystroglycan was normalized to aactinin expression (detected with mouse monoclonal antibody EA-53, Sigma). Band intensity was measured using ImageJ software. Unpaired t-test was used for statistical analyses. /dE3 mice) were analyzed. Minimal Feret's diameter was measured [38] for at least 2600 fibers for each group. The same number of fibers was used for quantification of fibers with centrally located nuclei. An additional group of 4-6-month-old dy 3K /dE3 animals was included for quantification of diaphragm fibers. Fibers from quadriceps muscle from 4-6-week-old wild-type (n = 3), dy 3K /dy 3K (n = 3) and dy 3K /dE3 mice (n = 3) were counted within a square of 64610 6 pixels 2 . Unpaired t-test was used for statistical analysis.
Treadmill exercise and Evans blue dye injection
Dy 3K /dE3 mice (n = 4) were exercised for 30 min on a treadmill Exer 6M (Columbus Instruments) at a downhill angle of 15u. During the first 2 min the speed was gradually increased from 7 m/min up to 14-16 m/min. Within 30 min after completed exercise the mice were injected i.p. with Evans blue dye (EBD) (Sigma Aldrich) dissolved in sterile saline (concentration: 0.5 mg EBD/0.05 ml saline; amount: 50 ml per 10 g body weight). After approximately 24 h, muscles were collected and quickly frozen in liquid nitrogen. Unexercised mice were injected with EBD and used as controls. Muscle cryosections (8 mm) were fixed in ice-cold acetone at 220uC for 10 min, washed and mounted with FluorSave (Calbiochem). By fluorescence microscopy analysis, EBD uptake into muscle fibers was visualized by red emission.
Cardiotoxin injections
Tibialis anterior muscles from 6 control (wild-type or dy 3K /+), 6 dy 3K /dy 3K and 6 dy 3K /dE3 mice were injected with cardiotoxin (10 mmol/L in saline). Control and dy 3K /dE3 mice were 2-3-month-old. Dy 3K /dy 3K mice were 3-week-old. Three mice from each group were sacrificed 4 days after injection and the other 3 after 11 days. Both injected and contralateral uninjected tibialis anterior muscles were collected and analyzed.
Electron microscopy and toluidine blue staining
Quadriceps femoris muscles, heart, diaphragm, sciatic nerves and spinal roots from wild-type, dy 3K /dy 3K and dy 3K /dE3 mice were fixed for 2 hours with 1.5% glutaraldehyde/1.5% paraformaldehyde, rinsed in Sörensen's phosphate buffer, post fixed in 1% OsO 4 and then embedded in Epon. Ultra thin sections were stained with uranyl acetate and lead citrate. Specimens were examined by transmission electron microscopy (Philips CM 10). Three to 4 animals from each group were analyzed.
Results
Generation of dy
3K /dy 3K mice overexpressing dE3LMa1 chain
We have generated mice overexpressing LMa1 chain devoid of LG4-5 domains (comprising the E3 fragment) under the control of a CMV enhancer and b-actin promoter (Fig. 1A and B) (dE3 mice), Mice overexpressing dE3LMa1 in skeletal muscle, peripheral nerve and heart were maintained (transgenic lines No. 3 and 4) ( Figure S1 , see also Fig. 2 ). The expression of truncated LMa1 chain was detected using antibodies against the N-terminal domains of LMa1 chain and the LG4 domain, respectively. Immunofluorescence staining with the antibody directed against N-terminal domains of LMa1 chain demonstrated patchy expression of truncated LMa1 chain in basement membranes of skeletal and cardiac muscle, and in endoneurium and perineurium of sciatic nerve of dE3 transgenic mice ( Figure S1 ). No staining was detected with the antibody directed towards LG4 domain, indicating the overexpression of truncated LMa1 chain. Staining with both antibodies was detected in LMa1TG mice overexpressing full-length LMa1 chain ( Figure S1 ) (described in 25) and it indicated a higher level and more homogeneous expression of LMa1 chain in these animals. Notably, overexpression of truncated LMa1 chain in mice revealed no discernible pathological phenotypes.
Next, dE3 mice from line 3 and 4 were further mated with mice carrying the mutation in Lama2 gene (dy 3K /+), to create mice that are devoid of LMa2 chain but instead overexpress dE3LMa1 chain (dy 3K /dE3 mice).
Expression of truncated LMa1 chain is upregulated upon LMa2 chain deficiency
We analyzed the expression of dE3LMa1 chain in dy 3K /dE3 mice in a similar manner as in dE3 mice (only the staining with the antibody against N-terminal domains is shown). Interestingly, upon LMa2 chain deficiency the truncated LMa1 chain was upregulated in all examined tissues (skeletal muscle, diaphragm, heart, peripheral nerve) compared to dE3 mice ( Fig. 2A) . Also, the expression levels seemed to reach those detected in dy 3K LMa1 mice overexpressing full-length LMa1 chain. We also noted intracellular staining of truncated LMa1 chain in skeletal muscle ( Fig. 2A) . Western blot analyses with an antibody against LMa1LG3 domain revealed even higher expression (approximately 2.5-fold) of dE3LMa1 chain in dy 3K /dE3 muscles compared to full-length LMa1 chain in dy 3K LMa1 muscles (Fig. 2B) . Therefore, we can rule out the possibility that the observed phenotype of dy 3K /dE3 mice described below is due to insufficient expression of truncated LMa1 chain. Also, it is clear that the regulatory mechanisms involved in LMa1 chain transgene expression are complex. We also assessed the expression of LMa4 and a5 chains. We and others have previously shown that expression of these two LM chains is upregulated in LMa2 chain deficient basement membranes [25, 39] (see also Figure S2 ). In dy 3K /dE3 mice, the muscle basement membrane expression of LMa4 and a5 chains was very similar to that of dy 3K /dy 3K mice ( Figure S2 ). Hence, we suggest that the compensatory increase of LMa4 and LMa5 chains has no beneficial effects in dy 3K /dE3 muscles (which are analyzed in detail in the next paragraphs).
Expression of integrin a7B and dystroglycan in dy 3K /dE3 tissues
We next evaluated the expression of integrin a7B and dystroglycan in dy 3K /dE3 muscles. Expression of integrin a7B is reduced at the sarcolemma of dy 3K /dy 3K limb and heart muscle but to a lesser extent in dy 3K /dy 3K diaphragm (Fig. 3A) . Notably, the expression of integrin a7B subunit was restored in dy 3K /dE3 limb, diaphragm and heart muscle ( Fig. 3A) . Similarly, also full-length LMa1 chain reconstituted integrin a7B chain at LMa2 chain deficient sarcolemma [32] . We further detected an approximately 4.5-fold upregulation of integrin a7B in dy 3K /dE3 skeletal muscle by immunoblotting experiments (Fig. 3B) .
LMa2 chain deficiency does not significantly alter a-dystroglycan glycosylation and b-dystroglycan expression at the sarcolemma [32] , probably because other ligands (e.g. perlecan) are still present. By immunofluorescence analyses, expression of adystroglycan also appeared normal in dy 3K /dE3 limb, diaphragm and heart muscle and in sciatic nerve (Fig. 4A ). In addition, we quantified expression of a-and b-dystroglycan and they remained the same in dy 3K /dE3 vs. control skeletal muscle (Fig. 4B) . All in all, these results suggest that integrin a7B is increased, whereas dystroglycans appear normally expressed in dy 3K /dE3 muscles.
Dy
3K /dy 3K mice with dE3LMa1 transgene have improved overall health Dy 3K /dy 3K mice completely deficient in LMa2 chain were previously described [2] . Briefly, these animals suffer from severe muscle wasting, growth retardation, peripheral neuropathy and die approximately 3-5 weeks after birth. As shown in Fig. 5 (Fig. 5A, middle panel) . However, some of the older dy 3K /dE3 animals look outwardly normal and are almost indistinguishable from their littermates (Fig. 5A, left panel) . Also, the ratio of quadriceps and tibialis anterior wet weight per body weight was similar in control and dy 3K /dE3 mice, whereas the ratio was significantly reduced in dy 3K /dy 3K mice (Fig. 5D and data not shown). Hence, muscle mass was maintained in proportion to the body size in dy 3K /dE3 mice. Nevertheless, most of dy 3K /dE3 mice display severe peripheral nerve abnormalities, as demonstrated by temporary hindleg paralysis (either one or occasionally two limbs) (Fig. 5A, arrow) . When lifted by the tail, they retract their hindlimbs toward the body. Still, dy 3K /dE3 mice perform much better in the locomotion activity test compared to dy 3K /dy 3K animals (Fig. 5E ), indicating that muscle function is largely preserved. Yet, dy 3K /dE3 mice move significantly less than control mice and this is supposedly due to the temporary paralysis (Fig. 5E) . Finally, we noted that serum kinase activity was significantly elevated in dy 3K /dE3 mice (Fig. 5F ), indicating that muscles may be dystrophic, despite improved general health.
In summary, survival during the first months of life and other features of the overall phenotype of dy 3K /dE3 mice are not greatly dependent on LMa1LG4-5.
DE3LMa1 transgene reduces the dystrophic pathology of skeletal muscles and significantly prevents dystrophic changes in diaphragm and heart
We next examined the morphology of dy 3K /dE3 skeletal and heart muscle. When isolating skeletal muscles from dy 3K /dE3 mice (5-week-old and 4-month-old and older), it could be macroscopically seen that muscles were only modestly wasted (see also Fig. 5D ). However, histological analyses of muscle revealed vast regeneration of muscle fibers in limb muscles, demonstrated by the presence of small fibers with centrally located nuclei (Fig. 6A) . Approximately 35% and 25% of 4-6-week-old dy 3K /dE3 quadriceps and triceps muscle fibers, respectively, contained centrally located nuclei and the numbers of centrally nucleated fibers did not differ significantly from dy 3K /dy 3K muscles (data not shown). The number of fibers in randomly selected areas was similar in wild-type and dy 3K /dE3 quadriceps muscle, but with a tendency of more fibers in dy 3K /dE3 mice (probably due to the presence of small regenerating fibers). Interestingly, a similar number of fibers was also noted in dy 3K /dy 3K quadriceps muscle ( Figure S3 ). However, average fiber diameter is smaller (data not shown) and instead muscle contains fibrotic tissue (see Figure 8A ). The number of fibers with centrally located was even higher in limb muscles of 4-month-old dy 3K /dE3 animals, indicating that pathology worsens over time (Fig. 6A and data not shown) . Nevertheless, these results indicate that dy 3K /dE3 muscles undergo damage but that the constant regeneration and muscle mass is maintained with age. Moreover, the diaphragm did not undergo degeneration/regeneration cycles and its morphology appeared near normal in 5-week-old and 4-month-old animals ( Fig. 6A-C) . Dy 3K /dy 3K diaphragm at 4-6-weeks of age displayed about 16% of regenerated muscle fibers with central nuclei. A significant reduction was found in dy 3K /dE3 diaphragm, both in young and older animals and the numbers did not differ significantly from wild-type diaphragm (Fig. 6B) . We also determined the muscle fiber size in 4-6-week-old diaphragm muscle. The fiber size distribution was shifted towards smaller fiber sizes in dy 3K /dy 3K animals, compared with wild-type muscles. Notably, the shift was largely prevented in dy 3K /dE3 muscles (Fig. 6C) . To demonstrate functional benefit conferred by the truncated LMa1 chain in diaphragm, we subjected dy 3K /dE3 mice to downhill treadmill exercise and sarcolemmal integrity was evaluated by Evans blue dye (EBD) accumulation. It has previously been shown that only occasional EBD-positive fibers are found in dy/dy muscles [40] . In agreement with these results, we also detected a few EBDpositive fibers in unexercised dy 3K /dy 3K muscles. We also observed a few EBD-positive fibers in unexercised dy 3K /dE3 limb muscles, but almost none in dy 3K /dE3 diaphragm (Fig. 7A) /dE3 limb muscles were susceptible to exercise-induced sarcolemmal injury as evidenced by increased uptake of EBD. Interestingly, downhill running induced very little damage in dy 3K /dE3 diaphragm (Fig. 7A) . Although EBD uptake in exercised dy 3K /dE3 limb muscles varied, both between animals and opposing limbs within the same animal, the diaphragm was consistently unaffected. Hence, truncated LMa1 chain prevents exercise-induced injury in diaphragm but not in limb muscles, indicating that different muscles have different requirements for LMa1LG4-5 domains.
The phenomenon of progressive muscle fiber damage in the limbs was further underscored by caspase-3 staining. Apoptosis has been shown to contribute to the severe dystrophic changes in muscles from MDC1A patients and LMa2 chain deficient mice [2, 41, 42] . In both dy 3K /dy 3K and dy 3K /dE3 muscles either single caspase-3 positive apoptotic fibers were detected or apoptosis was more robust (Fig. 7B) . In contrast, the muscles from LMa2 chain deficient mice overexpressing full-length LMa1 chain (dy 3K LMa1) were free of apoptotic fibers (no caspase-3 staining was observed, Fig. 7B ). Interestingly, apoptosis did not take place in dy 3K /dE3 diaphragms, whereas apoptotic fibers were present in diaphragms from dy 3K /dy 3K mice (Fig. 7B ). This data strongly suggests that LMa1LG4-5 protects limb muscles from apoptosis, most probably via dystroglycan binding, whereas truncated LMa1 chain is sufficient to prevent apoptosis in diaphragm muscle fibers.
Regardless of apoptotic cell death, muscle replacement with connective tissue, so evident in dy 3K /dy 3K mice [25] , was not very obvious in dy 3K /dE3 muscles (Fig. 6A) . This tendency was also demonstrated by tenascin-C staining. Tenascin-C has been shown to be upregulated and extends to the interstitium between muscle fibers in dy/dy and dy 3K /dy 3K mice [25, 43] . Some muscles from different dy 3K /dE3 animals showed moderate upregulation of tenascin-C (Fig. 8A , two individuals are shown, four animals were analyzed). However, tenascin-C expression was less pronounced than in dy 3K /dy 3K muscles. Also, some dy 3K /dE3 limb muscles did not display tenascin-C upregulation (Fig. 8A) . Moreover, diaphragm did not show any signs of fibrosis (Fig. 8A) .
Cardiomyopathy is not a major feature of MDC1A [1] . However, 2-month-old dy W /dy W hearts show infiltration of connective tissue [44] . Dy 3K /dy 3K mice probably die too early in order to develop heart fibrosis (data not shown). Therefore, we compared 5-6-month-old dy 3K /dE3 hearts with hearts from 8-week-old dy/dy mice, which show massive fibrosis in the ventricle wall (Fig. 8B) . As demonstrated by hematoxylin and eosin staining, dy 3K /dE3 hearts did not display any fibrotic lesions (Fig. 8) . This trend was further confirmed by absence of tenascin-C staining (Fig. 8B) .
In summary, LMa1LG4-5 domains are important for securing the mechanical stability of limb muscle fibers in LMa2 chain deficiency, most probably by binding to dystroglycan. Interestingly, LMa1LG4-5 domains are not involved in improvement of diaphragm and heart muscle morphology, indicating that other sites of LMa1 chain (most likely integrin a7b1 binding modules) are responsible for functional replacement of LMa2 chain in these muscles.
Skeletal muscle regeneration is not impaired in dy 3K /dE3 mice
Since muscle regeneration seemed to be continuously maintained in dy 3K /dE3 limb muscles (Fig. 6A) , we next analyzed their regenerative properties in more detail. We injected 2-3-month-old control, dy 3K /dE3 mice and 3-week-old dy 3K /dy 3K tibialis anterior with cardiotoxin to induce muscle damage and trigger muscle regeneration. Four days after injection many new fibers had reformed in all mice examined (data not shown). These fibers expressed embryonic myosin heavy chain, indicating an ongoing regeneration (Fig. 9B) . Surprisingly, the regeneration process clearly took place in the absence of LMa2 chain (although newly formed muscle cells in dy 3K /dy 3K tibialis anterior were rather small) (Fig. 9B) . Tibialis anterior from dy 3K /dE3 mice also showed normal initial regeneration, comparable to control mice. Most importantly, after 11 days post injection, dy 3K /dE3 muscles displayed the regeneration pattern characteristic for control mice /dE3 limb muscles and they were not distinguishable from each other (Fig. 9A) . Injected dy 3K /dE3 tibialis anterior muscles were tightly packed with big fibers. Also, the expression of embryonic myosin heavy chain was not detected after 11 days (Fig. 9B) . This data confirms that regeneration in the presence of truncated LMa1 chain is characterized with high capacity and maintenance. The regeneration in dy 3K /dy 3K mice was delayed and not as well-organized as in control and dy 3K /dE3 animals, since the muscle fibers in LMa2 chain deficient mice appeared to be less packed and surrounded by connective tissue (Fig. 9A) . Also, single fibers still expressed embryonic myosin heavy chain.
In summary, these data provide more insight into mechanism of muscle regeneration in LMa2 chain deficiency and indicate that LMa1 chain deprived of LG4-5 domains ensures proper regeneration. Therefore, binding to dystroglycan is not essential to ensure sufficient muscle regeneration and its maintenance.
LMa1LG4-5 is essential for myelination in peripheral nervous system in LMa2 chain deficiency MDC1A patients as well as dy 3K /dy 3K mice display dysmyelination neuropathy that leads to reduced conduction velocity of nerve impulses [45] [46] [47] . Unmyelinated axon bundles are prominent especially in spinal roots of LMa2 chain deficient mice. We have demonstrated before that overexpression of fulllength LMa1 chain in dy 3K /dy 3K peripheral nervous system largely corrects myelination defects [27] . Dy 3K /dE3 mice display hindleg paralysis and motor dysfunction. Morphology analyses of spinal roots and sciatic nerves confirmed that overexpression of truncated LMa1 chain did not correct the phenotype of the proximal part of peripheral nervous system. In spite of the presence of truncated LMa1 chain in both dorsal and ventral roots, large areas with unmyelinated axons (indicating incomplete axonal sorting) were evident in dy 3K /dE3 mice (Fig. 10) . Similar bundles of naked, unmyelinated axons have also been described in dorsal and ventral roots of dy 3K /dy 3K mice [27] . Importantly, this process was fully prevented upon overexpression of fulllength LMa1 chain in LMa2 chain deficient peripheral nervous system [27] , suggesting a role for LG4-5 domains in myelination processes.
Although myelination took place in the distal part of dy 3K /dE3 peripheral nervous system, sciatic nerve morphology was only partially rescued compared to dy 3K /dy 3K mice. Bundles of unsorted unmyelinated axons have been reported in dy 3K /dy 3K sciatic nerve [27] (see Fig. 10 ). Smaller, yet clearly visible patches of unsorted axons were also detected in dy 3K /dE3 sciatic nerves ( Fig. 10 and  11 ). While occasional unmyelinated axons are present in normal animals (Fig. 11, top panel) and they are known to be part of a healthy nerve, the bundles present in dy 3K /dE3 nerves were clearly bigger (Fig. 11, top panel) and more frequent (data not shown), than in control mice. Tomacula (thickened myelin sheaths) was observed in dy/dy mice [48] and we also detected these hypermyelinated axons in dy 3K /dy 3K animals (Fig. 10) . Fewer tomacula were seen in dy 3K /dE3 mice (Fig. 10) . Electron microscopy analyses of 2-4-month-old dy 3K /dE3 sciatic nerves revealed a whole spectrum of pathologies. Apart from axons with normal appearance (Fig. 11, top panel, yellow star) , many axons with myelin distortion and/or abnormal ovoid shape were detected, especially in the animals affected more severely with paralysis ( Fig. 11, top panel, 3 rd overview photo; middle panel and bottom panel). The post-myelination pathologies leading to axonal degeneration (Fig. 11A-E) included: myelin degradation, axon demyelination (B,C), myelin intrusions (A), excessive myelin outfoldings (A,D) and redundant loops (H). Degenerated axons often resembled Wallerian degeneration (Fig. 11E) [49] . Many Schwann cells detached from degenerating axons (Fig. 11E, arrow) and showed anomalous, most probably pre-apoptotic phenotype. Further abnormalities included presence of intra-axonal vacuoles (Fig. 11F), myelin infoldings (Fig. 11G) , different forms of hypermyelination ( Fig. 11I and J) and occasional onion bulbs (several concentric layers of Schwann cell cytoplasm around an axon, leading to demyelination) (Fig. 11K) . Schwann cells myelinating more than one axon (satellite axons) were found ( Fig. 11F and G) . This may point towards defective behavior of Schwann cells and as a consequence a defective myelination process. Many of the described abnormalities have not been associated with LMa2 chain deficiency before. However, redundant loop formation is characteristic for dy/dy mice [48] , and we also found many axons with redundant loops (Fig. 11H , and top panel overview). Redundant loop formation by Schwann cells and collapsing myelin that form ovoid, flat axons could contribute to axonal necrosis [50] . In conclusion, it is possible that upon LMa2 chain deficiency and in the absence of full-length LMa1 chain, Schwann cells acquire pathological properties and perform abnormal myelination. Furthermore, with age these Schwann cells could affect correctly assembled myelin layers, subsequently leading to axonal neuropathy.
These data show that the presence of truncated LMa1 chain did not prevent the possible age-related progression of pathological processes in dy 3K /dy 3K distal peripheral nervous system. Therefore, LMa1LG4-5 has a crucial role not only for myelination of the spinal roots, but also for correct myelination, maintenance of myelin, proper axon-Schwann cell interaction and peripheral nerve homeostasis in the distal peripheral nervous system. Various myelin and Schwann cell abnormalities have been shown to contribute to demyelination in different neuropathies [51] . Likewise, the myelin defects described above could influence the severity of observed neuropathy.
Basement membranes are not fully restored in the presence of truncated LM a1 chain LMa2 chain deficiency results in disrupted basement membranes around muscle and Schwann cells [2, 25, 27, 30, 46, 52, 53] . Overexpression of full-length LMa1 chain largely restores basement membranes in the neuromuscular system of dy 3K /dy 3K mice [25, 27] . In dy 3K /dE3 mice, basement membrane assembly was only partially re-established. Both in sciatic nerves and especially in skeletal muscle, basement membranes had a patchy appearance (Fig. 12, A and D) . In diaphragm muscle and heart, despite significant morphological improvement, basement membranes were also locally discontinuous (although to a lesser extent than in limb muscle), suggesting that the improvement of the phenotype is not entirely related to intact basement membranes in these organs. Nevertheless, basement membranes in dy 3K /dy 3K diaphragm and heart were more disrupted than in dy 3K /dE3 animals (Fig. 12, B and C) . M panel) . Overexpression of full-length LMa1 chain prevented the cell death in LMa2 chain deficient limb muscles. In contrast to limb muscles, only dy 3K /dy 3K diaphragm (Dia) contained apoptotic fibers, whereas the overexpression of both dE3LMa1 and full-length LMa1 chain prevented apoptosis in LMa2 chain deficient diaphragms. DAPI (blue) and an antibody against collagen IV (red) were used to co-visualize apoptotic fibers. Four animals from each group were analyzed. Bars, 50 mm. doi:10.1371/journal.pone.0011549.g007 Figure 8 . Analyses of fibrosis in skeletal muscle and heart. (A) Different wild-type (4-month-old), dy 3K /dy 3K (4-week-old) and dy 3K /dE3 (4-month-old) muscles (gastrocnemius, triceps, diaphragm) were stained with an antibody against tenascin-C. Occasionally tenascin-C is present in interstitial matrix of limb dy 3K /dE3 muscles, but it is absent from diaphragm. Note extensive tissue fibrosis in dy In summary, these data show that LMa1LG4-5 is partially required for basement membrane assembly and cell surface anchorage in the neuromuscular system.
Discussion
In this paper, we investigated the roles of LM C-terminal globular domains (and accordingly LM receptors dystroglycan and integrin) in muscle and nerve and analyzed the molecular mechanisms underlying LMa1 chain mediated rescue of LMa2 chain deficiency.
LMa1LG4-5 is dispensable for improvement of diaphragm and heart muscles, but not limb muscles in LMa1 chain rescued mice /dy 3K mice). Cardiopulmonary complications are often responsible for the early death in dystrophic patients but cardiomyopathy is not a common feature of LMa2 chain deficiency [1] . Considering that a severely dystrophic diaphragm will lead to pulmonary dysfunction, it is quite likely that the improved diaphragm in dy 3K /dE3 mice accounts for the increased survival, although we can not completely exclude that the expression of truncated LMa1 in other tissues (e.g. heart) is beneficial. Importantly, integrin a7B subunit is absent from dy 3K /dy 3K sarcolemma, but reconstituted in dy 3K /dE3 muscles. Hence, we propose that prolonged lifespan is secured via LMa1LG1-3 binding, most probably to integrin a7b1, in the diaphragm and possibly in the heart. Interestingly, while LMa1LG4-5 turned out to be dispensable for diaphragm and heart muscle, overexpression of LMa1 chain devoid of LG4-5 did not secure the complete correction of LMa2 chain deficient limb muscles. Although it is not surprising that LMa2 chain deficient peripheral nerve and muscle could respond differently to dE3LMa1 overexpression, it is somewhat unexpected that limb muscles and diaphragm would not be spared to the same degree, indicating an important difference in their properties or molecular signature in response to lack of a single protein domain. Our results also point toward diverse roles of LMa1LG4-5 when expressed in different muscle groups. For example, apoptosis has been shown to contribute to LMa2 chain deficient pathogenesis [54, 55] . In limb skeletal muscle, LMa1LG4-5 appeared to be critical for prevention of apoptosis of muscle fibers. However, this was not the case in diaphragm. Integrin a7b1 has been considered to be the major mediator of myofiber survival [29] . Now, we suggest that also LM binding to dystroglycan prevents apoptosis in limb muscle fibers. In support of this notion, dystroglycan binding to LMa2 chain has been shown to protect muscle cells in culture from apoptosis [56] . Yet, in some muscles, (e.g. diaphragm) integrin a7b1 could be the key player in apoptosis prevention.
LMa1LG4-5 is not involved in muscle regeneration in LMa1 chain rescued mice
Skeletal muscle regeneration depends on satellite cells, which express both dystroglycan and integrin a7b1 [10, 57] . In spite of muscle damage and cell death, dy 3K /dE3 muscles were able to regenerate and maintain muscle mass, both in normal conditions and when subjected to cardiotoxin injection. Also, mini-agrin increases the regenerative capacity of LMa2 chain deficient muscles. Since mini-agrin binds dystroglycan (rather that integrin a7b1), it is hypothesized that mini-agrin binding to dystroglycan is responsible for the restored regeneration [58, 59] and it has been demonstrated that dystroglycan activity in satellite cells is crucial for the maintenance of regeneration [10] . Yet, integrin a7 chain is also involved in skeletal muscle regeneration, as a7 integrin-null mice subjected to cardiotoxin injections exhibit a profound delay in muscle regeneration [57] . Hence, integrin a7 chain is most likely responsible for efficient muscle regeneration in dy 3K /dE3 mice since the dystroglycan binding domain is missing. We propose that the most aggravating step in MDC1A might be the lack of efficient regeneration due to abolished LMa2-integrin a7 interaction rather than impaired LMa2-dystroglycan interaction.
LMa1LG4-5 is vital for myelination in peripheral nerve in LMa1 chain rescued mice
None of the neuronal symptoms that occur in LMa2 chain deficiency were ameliorated by dE3LMa1 overexpression. This data together with our previous work [27] indicates a very important role for LMa1LG4-5 in LMa1 chain rescued peripheral nervous system. Interestingly, the phenotype of dy 3K /dy 3K and dy 3K / dE3 peripheral nervous system does not resemble the phenotype of any conditional knockout mice, where major LM receptors (dystroglycan, integrins b1 and b4) were depleted from Schwann cells [18] [19] [20] 60] . Furthermore, genetic inactivation of the a7 integrin chain does not affect peripheral nerve morphology and function [60] . Therefore, those receptors might just regulate the LMa2 chain/LMa1 chain interaction together with other receptors. Heparan sulfate proteoglycans syndecans presumably bind LMa1 via the LG4 domain [61] and are enriched in Schwann cells [62] , but syndecan-null mice do not display peripheral nerve defects [63] . Also, sulfatides have been shown to bind LMa1LG4-5 [64] and LMa2LG4-5 [65, 66] and to be expressed in peripheral nerves [67] , where they mediate basement membrane assembly and dystroglycan and integrin signaling [68] . Strikingly, lack of sulfatides and galactocerebrosides (another type of glycolipids) in mice results in similar myelin abnormalities in central nervous system as in dy 3K /dE3 distal peripheral nervous system. Hence, the LM receptor might belong to glycolipids [69] [70] [71] . Furthermore, monosialoganglioside GM1 has been shown to bind LM-111 and promote neurite outgrowth [72] . Therefore, the identification of a peripheral nerve LM receptor is an exciting task.
Basement membrane assembly in LMa1 chain rescued mice requires In early studies of LMa2 chain deficiency, lack of basement membranes was considered to be deleterious to the muscle fibers [2, 52, 73, 74] and to represent one of the MDC1A pathogenic mechanisms. Consequently, the approach of basement membrane restoration has been hypothesized to be beneficial for the improvement of the dystrophic muscle phenotype [25, 28, 44, 53] . Yet, continuous basement membranes are not strictly required for myelination in peripheral nervous system [46, 75] . Likewise, basement membranes are also patchy or less dense in dy 3K /dE3 mice diaphragm and heart muscle, indicating that continuous basement membranes are not vital for the complete correction of the dystrophic phenotype.
Our data helps to further understand the involvement of LMa1LG4-5 and LG1-3 in basement membrane assembly and point toward interesting basement membrane scaffolding mechanisms in the neuromuscular system in the absence of LMa1LG4-5. Exogenous LMa1LG4-5 has been shown to totally abolish the formation of basement membranes in vitro where it selectively blocked the cell-surface accumulation of a LM network [68, 76, 77] . In our in vivo model, despite lack of LMa1LG4-5, basement membranes showed only partial defects in cell surface anchoring. It is not excluded that integrins or other receptors that bind LMa1LG1-3, partially could compensate for lack of LMa1LG4-5 domain and dystroglycan/sulfatide binding and anchor the LM network to the cell surface. This accumulation, however, is not as efficient as in the presence of full-length LMa1 chain or mini-agrin [25, 27, 44, 53] , as basement membranes appear to be continuous only locally in dy 3K /dE3 mice. Therefore, it is possible that all LMa1LG domains and the cooperation between different LMa1LG1-5 receptors are important for the assembly of continuous basement membranes in vivo. This hypothesis is further substantiated in McKee et al., where all LG domains were shown to support LM tethering to cell surface [78, 79] . However, very recent data by Han et al., [15] confirms that dystroglycan, but not integrin a7b1, is involved in basement membrane anchorage and maintenance (rather than actual assembly) in muscle. Therefore, LMa1LG4-5 binding to dystroglycan could be important not only for basement membrane assembly in the muscle, but also for its maintenance. Figure S1 Expression of dE3LMa1 chain in limb skeletal muscle (SM), peripheral nerve (SN) and heart (He) of dE3 transgenic mice from lines No. 3 and 4. The two antibodies to detect truncated LMa1 chain were mAb200 and 1057+, which bind LG4 and Nterminal domains, respectively. Mosaic expression of dE3LMa1 chain was detected in transgenic neuromuscular tissues. Wild-type (WT) mice and full-length LMa1 chain transgenic animals (LMa1TG) were used as controls. Bars, 50 mm. Found at: doi:10.1371/journal.pone.0011549.s001 (3.82 MB TIF) Figure S2 Immunostaining of LMa4 and a5 chains. Crosssections of quadriceps femoris (Quad), triceps brachii (Tri) and diaphragm (Dia) from 6-week-old wild-type, dy3K/dy3K and dy3K/dE3 mice were stained with antibodies against LMa4 chain (A) and a5 chain (B), respectively. Expression of LMa4 and a5 chains is increased at the muscle basement area in dy3K/dy3K mice and remains increased in dy3K/dE3 muscles. Four dy3K/ dE3 animals were analyzed. Bar, 50 mm. 
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